Longitudinal Validation of CIRC Technologies

Not yet recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

August 31, 2035

Study Completion Date

August 31, 2037

Conditions
Cardiovascular DiseasesHeart FailureIschemic Heart DiseaseNon-ischemic CardiomyopathyValvular Heart DiseaseMetabolic CardiomyopathyCongenital Heart DiseaseAortic DiseasesAtrial FibrillationVentricular Fibrillation
All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

The Cleveland Clinic

OTHER

NCT07081711 - Longitudinal Validation of CIRC Technologies | Biotech Hunter | Biotech Hunter